We are live on ! Find out more
SMTI icon

Sanara MedTech
SMTI

21 hedge funds and large institutions have $9.72M invested in Sanara MedTech in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 1

13% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 8

5% more funds holding

Funds holding: 20 → 21 (+1)

3.98% less ownership

Funds ownership: 7.51% → 3.53% (-4%)

44% less capital invested

Capital invested by funds: $17.2M → $9.72M (-$7.49M)

Holders
21
Holders Change
+1
Holders Change %
+5%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
6
Reduced
1
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NRC
North Run Capital
Massachusetts
+$820K
2
SMG
Smart Money Group
Texas
+$292K
3
DC
Diametric Capital
Massachusetts
+$262K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$255K
5
BlackRock
BlackRock
New York
+$240K

Top Sellers

Rank Fund Capital Flow
1
OM
Opaleye Management
Massachusetts
-$7.01M
2
MS
Maven Securities
Jersey
-$2.03M
3
MIM
Monashee Investment Management
Massachusetts
-$1.37M
4
LCM
Laurion Capital Management
New York
-$433K
5
Millennium Management
Millennium Management
New York
-$419K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$3.12M +$217K +7,412 +10%
LCM
2
Laurion Capital Management
New York
$1.24M -$433K -14,801 -31%
NRC
3
North Run Capital
Massachusetts
$1.04M +$820K +28,063 New
DC
4
Diametric Capital
Massachusetts
$922K +$262K +8,978 +56%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$899K +$255K +8,733 +56%
PCM
6
Prelude Capital Management
New York
$575K +$149K +5,081 +48%
SIC
7
Salem Investment Counselors
North Carolina
$414K +$64.4K +2,202 +24%
BlackRock
8
BlackRock
New York
$303K +$240K +8,199 New
HI
9
Harbour Investments
Wisconsin
$296K – – –
Renaissance Technologies
10
Renaissance Technologies
New York
$270K +$213K +7,300 New
State Street
11
State Street
Massachusetts
$222K +$175K +6,000 New
SMG
12
Smart Money Group
Texas
$157K +$292K +10,000 New
Rockefeller Capital Management
13
Rockefeller Capital Management
New York
$110K +$58.5K +2,000 +200%
Royal Bank of Canada
14
Royal Bank of Canada
Ontario, Canada
$74K +$58.5K +2,000 New
Lazard Asset Management
15
Lazard Asset Management
New York
$41K +$32.8K +1,121 New
LF
16
Lee Financial
Texas
$18K – – –
Morgan Stanley
17
Morgan Stanley
New York
$15K +$11.5K +395 New
Osaic Holdings
18
Osaic Holdings
Arizona
$5K – – –
Wells Fargo
19
Wells Fargo
California
$1K – – –
OM
20
Opaleye Management
Massachusetts
– -$7.01M -225,000 Closed
MS
21
Maven Securities
Jersey
– -$2.03M -70,000 Closed
MIM
22
Monashee Investment Management
Massachusetts
– -$1.37M -44,060 Closed
Millennium Management
23
Millennium Management
New York
– -$419K -13,436 Closed
Susquehanna International Group
24
Susquehanna International Group
Pennsylvania
– -$323K -10,373 Closed
HF
25
HRT Financial
New York
– -$201K -6,461 Closed
1
2

SMTI Hedge Fund Activity: Q2 2021 in Review

21 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Sanara MedTech (SMTI) for Q2 2021, worth a combined $9.72M — down 44% from $17.2M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new SMTI positions and 8 closed out — a net gain of 1 holder — while 6 added to existing stakes and 1 trimmed.

The largest buyer was North Run Capital, opening a new position worth an estimated $820K. The largest seller was Opaleye Management, exiting entirely with an estimated $7.01M sold.

  • 21 institutional investors held Sanara MedTech (SMTI) as of Q2 2021, up from 20 in Q1 2021.
  • Funds reported $9.72M of Sanara MedTech stock for Q2 2021, down 44% quarter-over-quarter.
  • 9 funds opened new Sanara MedTech positions in Q2 2021 and 8 closed out, a net change of +1 holder.
  • The largest Sanara MedTech buyer in Q2 2021 was North Run Capital, an estimated $820K added.
  • The largest Sanara MedTech seller in Q2 2021 was Opaleye Management, an estimated $7.01M sold.

Based on aggregated 13F filings for Q2 2021.